PT  - JOURNAL ARTICLE
AU  - Buckley, Rita
ED  - Brand, Stephen R.
TI  - VT-1161 Emerges as Potential Treatment for Acute Vulvovaginal Candidiasis
DP  - 2015 Jul 23
TA  - MD Conference Express
PG  - 19--19
VI  - 15
IP  - 48
4099  - http://mdc.sagepub.com/content/15/48/19.2.short
4100  - http://mdc.sagepub.com/content/15/48/19.2.full
AB  - The novel agent VT-1161 is safe and as effective as fluconazole for treating acute vulvovaginal candidiasis infections. Furthermore, it is more effective than fluconazole for preventing recurrent vulvovaginal candidiasis infections, particularly at its mid- and high doses, according to results from a phase 2 dose-ranging study. VT-1161 is now being evaluated in patients with recurrent vulvovaginal candidiasis in the REVIVE trial.